Basic Information
ID: ALA2061056
Type: Binding
Description: Inhibition of P-glycoprotein-mediated daunorubicin efflux from human CCRF-CEM/VCR1000 cells after 240 secs by FACS flow cytometric analysis
Format: BAO_0000019
Organism: Homo sapiens
Target: P-glycoprotein 1(ALA4302)
Document: ALA2057194
Inhibition of P-glycoprotein-mediated daunorubicin efflux from human CCRF-CEM/VCR1000 cells after 240 secs by FACS flow cytometric analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA2061056
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 454.61 | 5.09 | 5.09 |
| 341.45 | 3.24 | 3.24 |
| 1202.63 | ||
| 494.68 | 8.10 | 8.10 |
| 367.49 | 3.73 | 3.73 |
| 459.59 | 4.23 | 4.23 |
| 431.53 | 3.64 | 3.64 |
| 434.51 | 3.62 | 3.62 |
| 646.74 | 6.37 | 6.37 |
| 472.63 | 4.68 | 4.68 |
| 563.65 | 5.56 | 5.56 |
| 609.72 | 6.02 | 6.02 |
| 527.62 | 5.21 | 5.21 |
| 1214.65 | ||
| 341.41 | 1.99 | 1.99 |
| 339.44 | 3.14 | 3.14 |
| 444.58 | 4.10 | 4.10 |
| 444.58 | 4.10 | 4.10 |
| 444.58 | 4.10 | 4.10 |
| 434.51 | 3.62 | 3.62 |
| 434.51 | 3.62 | 3.62 |
| 339.44 | 3.14 | 3.14 |
| 339.44 | 3.14 | 3.14 |
| 341.41 | 1.99 | 1.99 |
| 430.55 | 3.79 | 3.79 |
| 430.55 | 3.79 | 3.79 |
| 327.42 | 2.97 | 2.97 |
| 473.57 | 3.82 | 3.82 |
| 489.64 | 3.98 | 3.98 |
| 594.71 | 3.95 | 3.95 |
| 546.66 | 3.23 | 3.23 |